MyClin: clinical trial software company expands to new Old City office - Technical.ly Philly

Business

Jan. 24, 2013 9:30 am

MyClin: clinical trial software company expands to new Old City office

Old City startup MyClin wants to make running clinical trials effortless. (We’re talking about the studies that researchers conduct to test drugs or medical devices on humans before they go to market.) MyClin’s software aims to facilitate communication between all the moving parts of a clinical trial. With its online platform, those running clinical trials can […]

Old City startup MyClin wants to make running clinical trials effortless. (We’re talking about the studies that researchers conduct to test drugs or medical devices on humans before they go to market.)

MyClin’s software aims to facilitate communication between all the moving parts of a clinical trial. With its online platform, those running clinical trials can share documents, conduct surveys and store important information. And the bootstrapped company has gained some traction: it has half a dozen clients, said founder James Denmark, and its software has been used in two dozen clinical trials.

Visit MyClin’s website here.

MyClin recently moved from Old City coworking spot Indy Hall to its own office around the corner at 118 Church Street near N3rd Street. The move was to accommodate company growth as well as to “be seen as a legitimate vendor,” Denmark said, since its client base is moving toward more “mainstream, conservative bio-pharma companies.”

Visit MyClin’s new office at its Jan. 25 open house.

Denmark, 42, spent more than two decades working in clinical trial services industry before he founded MyClin in 2008. He lives in Bucks County but said he opened up shop in Philly because of Indy Hall.

“I […] brought the company into Philly against the advice of my accountant to gain access to the vibrant community I found at Indy Hall,” he wrote in an email.

Read more about MyClin on MedCityNews here.

 

Companies: Indy Hall, MyClin
People: James Denmark
Projects: N3rd Street
-30-
CONTRIBUTE TO THE
JOURNALISM FUND

Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

Inside University City’s push to get those without four-year degrees into STEM careers

University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO

Success in life sciences begets more success: What Philly leaders say about the industry’s growth

SPONSORED

Philly

Say ‘Ahoy’ to the technical opportunities at Vanguard

Philadelphia

Perpay

UX Designer

Apply Now

Chesterbrook, PA

Deacom

Inside Sales Representative

Apply Now

Horsham, PA

Penn Mutual

Product Owner/Business Transformation Specialist

Apply Now

Money Moves: These 5 Philly-area companies just raised millions in VC funding

Carisma Therapeutics raised nearly $60M in Series A funding. Now what?

A Center City biotech company is using an algorithm to help patients with memory loss

SPONSORED

Philly

Packed with growth opportunities, WSFS Bank moves into Philly

Center City

Inspire

Member Experience Specialist

Apply Now

Philadelphia, PA

Perpay

Frontend Engineer

Apply Now

Philadelphia, PA

Perpay

Relationship Marketer

Apply Now

Sign-up for daily news updates from Technical.ly Philadelphia

Do NOT follow this link or you will be banned from the site!